Cargando…
A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia
Treatment-resistant schizophrenia (TRS) will affect about one in three patients with schizophrenia. Clozapine is the only treatment approved for TRS, and patients should be treated as soon as possible to improve their chances of achieving remission. Despite its effectiveness, concern over side effec...
Autores principales: | Correll, C. U., Agid, Ofer, Crespo-Facorro, Benedicto, de Bartolomeis, Andrea, Fagiolini, Andrea, Seppälä, Niko, Howes, Oliver D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243911/ https://www.ncbi.nlm.nih.gov/pubmed/35759211 http://dx.doi.org/10.1007/s40263-022-00932-2 |
Ejemplares similares
-
Correction: A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia
por: Correll, C. U., et al.
Publicado: (2022) -
Therapy for HIV-associated cryptococcal meningitis: a case report demonstrating a new treatment approach emphasizing updated treatment guidelines
por: Hachey, David M., et al.
Publicado: (2023) -
The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research
por: Potkin, Steven G., et al.
Publicado: (2020) -
Brain Structural Effects of Antipsychotic Treatment in Schizophrenia: A Systematic Review
por: Roiz-Santiañez, Roberto, et al.
Publicado: (2015) -
Pyoderma Gangrenosum: Treatment Options
por: Dissemond, Joachim, et al.
Publicado: (2023)